Involvement of DKK1 Secreted From Adipose-Derived Stem Cells in Alopecia Areata

    November 2023 in “ Cell Proliferation ”
    Nahyun Choi, J.-U. Hwang, Doo Yeong Kim, Jino Kim, Seung Yong Song, Jong‐Hyuk Sung
    Image of study
    TLDR A protein from fat-derived stem cells, DKK1, is linked to hair loss and blocking it may help treat alopecia areata.
    The study investigated the role of DKK1, a protein secreted from adipose-derived stem cells (ASCs), in alopecia areata (AA), a condition causing hair loss. High DKK1 expression was found in AA patients, suggesting a correlation between DKK1 and hair loss. DKK1 was found to hinder hair follicle enlargement and restrict the proliferation of hair follicle stem cells. However, inhibiting DKK1 stimulated hair growth. The researchers created DKK1 knockout ASCs (DKK1-KO-ASCs) which showed increased hair growth-promoting effects and reduced inflammatory responses, making them a promising cell therapy for treating AA. The DKK1 knockout led to the activation of the WNT pathway, promoting hair growth, and the inactivation of the NF-kB pathway, reducing inflammation.
    Discuss this study in the Community →

    Research cited in this study

    19 / 19 results

    Related Community Posts Join

    6 / 32 results

      community A concise, easy-to-understand post on Androgenic Alopecia theory and its practical applications

      in Research/Science  91 upvotes 3 years ago
      The mechanism of Androgenic Alopecia and practical applications of treatments like Minoxidil, Finasteride, RU58841, dermarolling, scalp massages, anti-fungals, progesterone, estrogen, PPAR-γ activators, reducing oxidative stress, and scalp exercises. It explains why DHT is important in AA and how other factors might be involved such as hypoxia, increased DKK-1 expression, morphological changes to the scalp, skull growth during childhood/puberty, and blood flow.

      community HLT Megathread on HMI-115 (key takeaways in comments)

      in Research/Science  39 upvotes 3 years ago
      HMI-115, a newly discovered hair loss treatment that could potentially be effective for those with diffuse thinning and telogen effluvium. It is based on prolactin receptor antagonist signaling and has already undergone Phase I trials in women, with potential commercialization by 2027.

      community Fevipiprant 2019!

       16 upvotes 9 years ago
      The conversation discusses Fevipiprant, an asthma drug that may block CRTH2 and potentially stop male pattern baldness (MPB) without inhibiting DHT. It also mentions the use of finasteride and dutasteride for hair loss.

      community Trialing the probiotics BB536, PTA 6475 so you don’t have to

      in Research/Science  74 upvotes 9 months ago
      Probiotics like L. reuteri ATCC PTA 6475 and B. longum BB536 may improve hair growth and density by reducing inflammation and reversing DHT damage. The user is trialing these probiotics personally, ordering them from the U.S. to Canada, and plans to continue if no adverse effects occur.

      community Has anyone used Magnesium L-Threonate ?

       74 upvotes 7 years ago
      Magnesium L-Threonate may help treat balding by reducing DKK-1 expression without affecting DHT. Users discuss its potential effectiveness and application methods, with some considering trying it topically.

    Similar Research

    5 / 707 results